How to Avoid Desk Rejection at JAMA

How to avoid desk rejection at JAMA comes down to one thing: stop asking whether the study is strong for its specialty and start asking whether it matters to general medicine. JAMA is not trying to publish the best paper in cardiology, oncology, endocrinology, or infectious disease. It is trying to publish work that broad physicians will immediately understand, trust, and use.

That is why good papers get rejected fast. The science may be rigorous. The statistics may be clean. The clinical topic may be important. But if the editor sees the natural audience as one specialty rather than a broad physician readership, the submission starts to look like the wrong journal even before peer review begins.

Related reading: JAMA journal overview • JAMA impact factor • How to choose the right journal • Desk rejection support • Pre-submission checklist

How to avoid desk rejection at JAMA: what editors decide first

JAMA editors are making a consequence judgment long before they are making a detailed methods judgment. They want to know four things fast.

• Who cares? Will a broad physician audience care, not just one department or subspecialty?
• What changes? Does this paper change care, interpretation, policy, screening, risk framing, or another real medical decision?
• How hard is it to trust? Does the design look sturdy enough to survive rapid scrutiny?
• Is the payoff obvious? Can the importance be understood from the title and abstract without reading the paper like a methods reviewer?

If the paper looks narrow, soft-ended, or overstated, the triage decision can happen very quickly.

Why strong studies still get desk rejected at JAMA

1. The study belongs in a specialty journal

This is the most common problem. A paper can be excellent and still be a better fit for JAMA Oncology, Circulation, Clinical Infectious Diseases, or another field-leading venue. General medicine is not the same thing as high prestige. It is a different audience test.

2. The primary endpoint is one step too far from real care

JAMA responds much better to outcomes that affect actual clinical decisions than to papers built on soft surrogates, intermediate biomarkers, or abstract model logic. If the endpoint matters only after several layers of interpretation, the paper feels weaker for a broad medical journal.

3. The methods feel reviewable but vulnerable

Editors know which designs invite immediate reviewer doubt. Fragile subgroup stories, thin causal logic, unclear confounding control, and heavy reliance on retrospective convenience data all make a manuscript feel expensive to review. JAMA does publish observational work. But it needs to look unusually disciplined.

4. The abstract is written for insiders

A lot of papers lose altitude because the first page assumes the reader already lives in the disease area. JAMA abstracts need to work for physicians who are smart but not embedded in your specialty vocabulary.

5. The discussion tries to force practice relevance

Editors at this level can spot inflated clinical framing quickly. If the paper sounds practice-changing but the data still feel modest, trust falls. JAMA is far more receptive to crisp, earned claims than to ambitious interpretation.

6. The manuscript answers a real question, but not a broad one

Some studies answer useful questions that matter deeply to one community. That alone does not make them JAMA papers. The journal wants questions that travel across general medical readership, not only across one disease niche.

What a reviewable JAMA manuscript looks like

The best JAMA submissions usually feel easy to explain in plain language. That simplicity is not a sign of weak science. It is a sign that the paper knows exactly which decision it changes.

• The title names the clinical issue clearly.
• The abstract gets to the consequence early.
• The primary outcome feels worth a general physician's attention.
• The methods look hard to dismiss on first inspection.
• The discussion sounds measured enough that editors trust it.

If your paper is hard to summarize without a paragraph of specialty context, it is already at a disadvantage.

What JAMA editors compare your paper against

They are comparing your submission against recent original investigations that feel immediately legible to broad medicine. That matters more than many authors think. The comparison is not "Is this good for my field?" The comparison is "Does this belong next to the papers JAMA already chose for a wide clinical audience?"

Those benchmark papers usually have three traits. First, the question is obvious and medically real. Second, the evidence looks sturdy enough that the editor does not need to imagine reviewers repairing the manuscript. Third, the implication is easy to summarize without specialty shorthand. If your paper needs ten minutes of disease-area context before the relevance becomes visible, it will usually look smaller in that lineup.

This is also why some very good papers feel wrong for JAMA even when the topic is important. Importance inside a field is not the same as relevance to broad medicine. Editors are trying to pick papers that can cross departments, not just dominate one conversation.

Questions that usually travel in JAMA and questions that usually do not

A rough rule helps here. Papers tend to travel when they clarify a decision that many physicians recognize already. They tend not to travel when they answer a narrower technical question that mostly matters after a specialist translates it.

• More likely to travel: treatment comparisons, practice implications, large risk questions, screening decisions, high-authority safety findings.
• Less likely to travel: narrow mechanistic correlates, specialty workflow tweaks, surrogate-heavy analyses with weak patient consequence, or papers whose main value is to one clinical niche.

That does not make the second group weak science. It just means the readership fit is different. Authors lose time when they use JAMA as a prestige test instead of an audience test.

One more useful check is to hand the title and abstract to a physician outside the specialty and ask what the paper changes. If the answer comes back as "interesting, but mostly for that field," the editor may feel the same thing. JAMA rewards manuscripts that survive that test cleanly.

The fast pre-submit audit for JAMA

Before you submit, answer these questions bluntly.

• Decision test: what exact clinical decision becomes clearer because of this paper?
• Audience test: would a hospitalist, internist, or general clinician care even if this is not their main field?
• Endpoint test: are the outcomes close enough to patient care to feel meaningful without translation?
• Credibility test: what is the first methods attack an editor would expect reviewers to make?
• Fit test: are you choosing JAMA because the readership fits, or because the brand is tempting?

If those answers feel wobbly, the journal choice is probably wobbly too.

What to fix before you send a JAMA submission

• Rewrite the abstract for broad physicians rather than specialists.
• Lead with the endpoint that matters most to care, not the most statistically complex endpoint.
• Cut field-specific framing that narrows perceived audience.
• Make the methods credibility visible early. Do not hide the hardest design question.
• Lower any sentence that implies practice change unless the data truly carry that weight.
• Make the first page answer, in plain language, why this matters to general medicine now.

What the cover letter should do

The cover letter should make one clean case: why this manuscript belongs in a broad medical journal now. Not why the disease is important in general. Not why the field cares. Why a wide physician readership should spend time on this paper now.

If that case turns fuzzy as you write it, the submission is telling you something useful.

When JAMA is probably the wrong target

If the natural reader is still one specialty group, a top field journal is often the smarter first move. If the endpoint is indirect, the design still looks exposed, or the implication is more technical than broadly clinical, JAMA may cost you time without giving you a real shot.

Related: Manuscript revision help • Respond to reviewers

Checklist before submitting to JAMA

• Can you name the exact broad clinical decision the paper informs?
• Are the primary outcomes strong enough for a general medical journal?
• Does the study design look hard to dismiss quickly?
• Would a broad physician audience care outside your specialty?
• Does the abstract surface the consequence in the first few lines?
• Are the claims as tight as the data?

FAQ

Can JAMA publish specialty studies?
Yes, but the paper still needs to matter beyond that specialty. The readership test is much broader than many authors expect.

Are observational studies automatically weak for JAMA?
No. But they need unusual design discipline, strong causal reasoning, and an outcome that general physicians care about.

What is the biggest author mistake?
Treating JAMA like a prestige upgrade for any strong specialty paper instead of asking whether the manuscript actually belongs in general medicine.

Final take

To avoid desk rejection at JAMA, make the paper feel broadly clinical, methodologically sturdy, and immediately useful to general medicine. If the real audience is still one specialty, the editor will feel that before review starts.